Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Chiu

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2017
Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with DaratumumabJakub Krejcik, Kris A Frerichs, Inger S Nijhof, et al.
The Lancet. Infectious Diseases|February 11, 2023
Use of cidofovir in a patient with severe mpox and uncontrolled HIV infectionAdam Stafford, Stephanie Rimmer, Mark Gilchrist, et al.
The New England Journal of Medicine|December 13, 2017
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated MyelomaMaría-Victoria Mateos, Meletios A Dimopoulos, Michele Cavo, et al.
Cell|May 16, 2017
Metabolic Phenotypes of Response to Vaccination in HumansShuzhao Li, Nicole L Sullivan, Nadine Rouphael, et al.
The Journal of Clinical Investigation|December 10, 2019
Epitope-specific airway-resident CD4+ T cell dynamics during experimental human RSV infectionAleks Guvenel, Agnieszka Jozwik, Stephanie Ascough, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 3, 2024
Regulatory workshop on challenge strain development and GMP manufacture - A stakeholder meeting reportNicoletta Corti, Christopher Chiu, Rebecca J Cox, et al.
Nature Communications|October 26, 2018
A crowdsourced analysis to identify ab initio molecular signatures predictive of susceptibility to viral infectionSlim Fourati, Aarthi Talla, Mehrad Mahmoudian, et al.
The New England Journal of Medicine|May 30, 2019
Daratumumab plus Lenalidomide and Dexamethasone for Untreated MyelomaThierry Facon, Shaji Kumar, Torben Plesner, et al.
Science Immunology|March 11, 2021
Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19Ryan S Thwaites, Ashley Sanchez Sevilla Uruchurtu, Matthew K Siggins, et al.
Nature Communications|December 7, 2025
Pre-existing and early cellular immune factors correlate with functionally complete protection against primary controlled human SARS-CoV-2 infectionHelen R Wagstaffe, Ryan S Thwaites, Jasmin K Sidhu, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2017
Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with DaratumumabJakub Krejcik, Kris A Frerichs, Inger S Nijhof, et al.
The Lancet. Infectious Diseases|February 11, 2023
Use of cidofovir in a patient with severe mpox and uncontrolled HIV infectionAdam Stafford, Stephanie Rimmer, Mark Gilchrist, et al.
The New England Journal of Medicine|December 13, 2017
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated MyelomaMaría-Victoria Mateos, Meletios A Dimopoulos, Michele Cavo, et al.
Cell|May 16, 2017
Metabolic Phenotypes of Response to Vaccination in HumansShuzhao Li, Nicole L Sullivan, Nadine Rouphael, et al.
The Journal of Clinical Investigation|December 10, 2019
Epitope-specific airway-resident CD4+ T cell dynamics during experimental human RSV infectionAleks Guvenel, Agnieszka Jozwik, Stephanie Ascough, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 3, 2024
Regulatory workshop on challenge strain development and GMP manufacture - A stakeholder meeting reportNicoletta Corti, Christopher Chiu, Rebecca J Cox, et al.
Nature Communications|October 26, 2018
A crowdsourced analysis to identify ab initio molecular signatures predictive of susceptibility to viral infectionSlim Fourati, Aarthi Talla, Mehrad Mahmoudian, et al.
The New England Journal of Medicine|May 30, 2019
Daratumumab plus Lenalidomide and Dexamethasone for Untreated MyelomaThierry Facon, Shaji Kumar, Torben Plesner, et al.
Science Immunology|March 11, 2021
Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19Ryan S Thwaites, Ashley Sanchez Sevilla Uruchurtu, Matthew K Siggins, et al.
Nature Communications|December 7, 2025
Pre-existing and early cellular immune factors correlate with functionally complete protection against primary controlled human SARS-CoV-2 infectionHelen R Wagstaffe, Ryan S Thwaites, Jasmin K Sidhu, et al.
Pageof 13